Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.70 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.66 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.66 |
| ▸ | TNKS | O95271 | 1/20 | 0.66 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.66 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.66 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.66 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.66 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.66 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.66 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.66 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.66 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.66 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.66 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 3/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cinnamic Acid SCHEMBL9102682 | 1.00 | CYP1B1 (0.70) | CYP1B1HCAR2HDAC3TNKSHDAC4 | |
| Cinnamic Acid SCHEMBL10803545 | 0.87 | HCAR2 (0.79) | CYP1B1HCAR2HDAC3TNKSHDAC4 | |
| Cinnamic Acid SCHEMBL10996900 | 0.87 | HCAR2 (0.79) | CYP1B1HCAR2HDAC3TNKSHDAC4 | |
| Cinnamic Acid SCHEMBL11878212 | 0.85 | HCAR2 (0.76) | CYP1B1HCAR2HDAC3TNKSHDAC4 | |
| Cinnamic Acid SCHEMBL11878207 | 0.85 | HCAR2 (0.76) | CYP1B1HCAR2HDAC3TNKSHDAC4 | |
| Benzene SCHEMBL6912055 | 0.85 | HCAR2 (0.68) | CYP1B1HCAR2HDAC3TNKSHDAC4 | |
| Cinnamic Acid SCHEMBL7261608 | 0.85 | HCAR2 (0.63) | CYP1B1HCAR2HDAC3TNKSHDAC4 | |
| SCHEMBL70241 | 0.83 | HCAR2 (0.65) | HCAR2HDAC3TNKSHDAC4HDAC1 | |
| SCHEMBL143559 | 0.83 | CA12 (0.65) | CYP1B1HCAR2HDAC3TNKSHDAC4 | |
| SCHEMBL1001682 | 0.83 | CA12 (0.65) | CYP1B1HCAR2HDAC3TNKSHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6696069-B2 | ORGANIC SULFONATE, PHOSPHATE OR SULFATE | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-24 | — | — | US | disclosed |
| US-20020041890-A1 | Skin care cosmetic compositions containing phosphates and/or sulfates of branched alcohols and/or ethoxylates thereof | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-04-11 | — | — | US | disclosed |
| WO-2002002072-A2 | SKIN CARE COSMETIC COMPOSITIONS CONTAINING PHOSPHATES AND/OR SULFATES OF BRANCHED ALCOHOLS AND/OR ETHOXYLATES THEREOF | UNILEVER PLC (GB) | 2002-01-10 | — | — | WO | disclosed |
| EP-0713383-A1 | SUNSCREEN AGENTS | UNILEVER PLC (GB) | 1996-05-29 | — | — | EP | disclosed |
| WO-1995005150-A1 | SUNSCREEN AGENTS | UNILEVER PLC (GB) | 1995-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020041890-A1 | Skin care cosmetic compositions containing phosphates and/or sulfates of branched alcohols and/or ethoxylates thereof | CUTA, EBP, EYA3 | CYP1B1 3550/4885HCAR2 3356/4885HDAC3 3341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.